Page last updated: 2024-09-03

sr 27897 and apomorphine

sr 27897 has been researched along with apomorphine in 3 studies

Compound Research Comparison

Studies
(sr 27897)
Trials
(sr 27897)
Recent Studies (post-2010)
(sr 27897)
Studies
(apomorphine)
Trials
(apomorphine)
Recent Studies (post-2010) (apomorphine)
483169,205287780

Protein Interaction Comparison

ProteinTaxonomysr 27897 (IC50)apomorphine (IC50)
Tryptophan 5-hydroxylase 1Rattus norvegicus (Norway rat)0.22
D(2) dopamine receptorHomo sapiens (human)0.0146
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)7.75
DRattus norvegicus (Norway rat)0.4744
D(3) dopamine receptorRattus norvegicus (Norway rat)0.1432
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)0.063
D(2) dopamine receptorBos taurus (cattle)0.3385
D(1A) dopamine receptorHomo sapiens (human)0.025
D(4) dopamine receptorHomo sapiens (human)0.025
D(1B) dopamine receptorHomo sapiens (human)0.025
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)0.063
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)0.063
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)7.75
D(1B) dopamine receptorRattus norvegicus (Norway rat)0.1432
D(4) dopamine receptorRattus norvegicus (Norway rat)0.1432
D(3) dopamine receptorHomo sapiens (human)0.025
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)7.75
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0813
E3 ubiquitin-protein ligase Mdm2Homo sapiens (human)0.205
5-hydroxytryptamine receptor 4 Rattus norvegicus (Norway rat)1.35
DBos taurus (cattle)0.3385

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gueudet, C; Gully, D; Le Fur, G; Santucci, V; Soubrie, P; Thurneyssen, O1
Arnone, M; Gonalons, N; Gueudet, C; Gully, D; Heaulme, M; Keane, P; Le Fur, G; Poncelet, M; Santucci, V; Thurneyssen, O1
Felicio, LF; Ferreira, FS; Nasello, AG; Sassatani, AS; Tieppo, CA1

Other Studies

3 other study(ies) available for sr 27897 and apomorphine

ArticleYear
The CCKA receptor antagonist SR 27897 differentially influences the activity of A9 and A10 dopaminergic neurons in the rat.
    Annals of the New York Academy of Sciences, 1994, Mar-23, Volume: 713

    Topics: Animals; Apomorphine; Benzodiazepinones; Devazepide; Dopamine; Indoleacetic Acids; Male; Mesencephalon; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Sincalide; Thiazoles

1994
Neurobehavioural effects of SR 27897, a selective cholecystokinin type A (CCK-A) receptor antagonist.
    Naunyn-Schmiedeberg's archives of pharmacology, 1993, Volume: 348, Issue:1

    Topics: Animals; Apomorphine; Brain; Cyclic GMP; Dose-Response Relationship, Drug; Female; Indoleacetic Acids; Male; Mice; Motor Activity; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Cholecystokinin; Thiazoles

1993
Opposite modulation of apomorphine- or amphetamine-induced stereotypy by antagonists of CCK receptors.
    European journal of pharmacology, 2000, Jan-10, Volume: 387, Issue:2

    Topics: Amphetamine; Animals; Apomorphine; Benzodiazepinones; Dopamine; Indoleacetic Acids; Male; Phenylurea Compounds; Rats; Rats, Wistar; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Stereotyped Behavior; Thiazoles

2000